hk331 (Hycult Biotech)
Hycult Biotech is a verified supplier 
Hycult Biotech manufactures this product 
93
Structured Review
Hycult Biotech
hk331
Hk331, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/HK331/SAP%2C+Human%2C+ELISA+kit/pmc05734420-74-28-20
Average 93 stars, based on 18 article reviews
Hk331, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/HK331/SAP%2C+Human%2C+ELISA+kit/pmc05734420-74-28-20
Average 93 stars, based on 18 article reviews
hk331 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Clinical Diagnostic Utility of IP-10 and LAM Antigen Levels for the Diagnosis of Tuberculous Pleural Effusions in a High Burden Setting Article Snippet: For nucleic-acid-amplification the Amplified Tuberculosis Direct Test (Genprobe, San Diego, CA) was performed in duplicate according to the manufacturer's instructions (H37Rv served as a positive control and M. intracellulare served as the negative control) and readouts were obtained using a Leader 50 Luminometer (Genprobe, San Diego, CA). .. IP-10 levels were measured, according to the manufacturer's instructions, using a standardized Article Title: A comparative analysis of human bone marrow-resident and peripheral memory B cells. Article Snippet: .. DEFA1-3 concentration was determined with a Article Title: Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children Article Snippet: .. Levels of SAA, SAP, PTX3, CFP and CRP were determined in twofold diluted plasma by ELISA following the manufacturer’s instructions (Hycult Biotech, Uden, The Netherlands, catalogue numbers HK333, Article Title: Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects. Article Snippet: This phase 1 study characterized the safety, tolerability, pharmacokinetics, and pharmacodynamics of miridesap (GSK2315698) following an intravenous (IV) infusion in healthy Japanese men.. Subjects in Cohort 1 received 1-hour IV infusions of 10, 20, and 40 mg of miridesap or placebo, and subjects in Cohort 2 received a 15-hour IV infusion of 20 mg/h of miridesap or placebo.. No treatment-related adverse events were reported. Concentration Assay:Article Title: A comparative analysis of human bone marrow-resident and peripheral memory B cells. Article Snippet: .. DEFA1-3 concentration was determined with a Clinical Proteomics:Article Title: Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children Article Snippet: .. Levels of SAA, SAP, PTX3, CFP and CRP were determined in twofold diluted plasma by ELISA following the manufacturer’s instructions (Hycult Biotech, Uden, The Netherlands, catalogue numbers HK333, other:Article Title: Serum Amyloid P Attenuates Hypertrophic Scarring in Large Animal Models. Article Snippet: Introduction: This study’s purpose was to (1)determine the effect of locally administered serum amyloid P (SAP) on the development of hypertrophic scars (HTS) in porcine and rabbit HTS models and (2)determine the pharmacokinetics of systemically administered SAP and its effect on circulating fibrocyte quantities.. Methods: Two large animal (New Zealand White Rabbit and Female Red Duroc Pigs) HTS models were utilized to study the effects of daily local injections of SAP immediately post wounding (x5 d in rabbits; x7 d in pigs) on HTS development as measured by scar elevation index , scar area, wound closure, andmolecular expression studies of scar components.. For SAP pharmacokinetics, total and human SAP levels in porcine blood were measured at regular intervals following intravenous administration of human SAP. Modification:Article Title: Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects. Article Snippet: This phase 1 study characterized the safety, tolerability, pharmacokinetics, and pharmacodynamics of miridesap (GSK2315698) following an intravenous (IV) infusion in healthy Japanese men.. Subjects in Cohort 1 received 1-hour IV infusions of 10, 20, and 40 mg of miridesap or placebo, and subjects in Cohort 2 received a 15-hour IV infusion of 20 mg/h of miridesap or placebo.. No treatment-related adverse events were reported. Purification:Article Title: Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects. Article Snippet: This phase 1 study characterized the safety, tolerability, pharmacokinetics, and pharmacodynamics of miridesap (GSK2315698) following an intravenous (IV) infusion in healthy Japanese men.. Subjects in Cohort 1 received 1-hour IV infusions of 10, 20, and 40 mg of miridesap or placebo, and subjects in Cohort 2 received a 15-hour IV infusion of 20 mg/h of miridesap or placebo.. No treatment-related adverse events were reported. |